Currently Externally Funded Projects

• PROP-AD: Propagation behaviour of peripheral amyloid-β towards brain structures: effects of the blood-brain barrier (JPND / EU / NFR)
• PhytoAD: St. John’s wort as Alzheimer’s treatment – New ways of identification, exploitation and use of natural resources (SAW Leibniz Society Grant / EFRE)
• Blood-brain barrier ABCG2 function in Alzheimer´s disease – LSC14-008 funded
• ABC-HC: The importance of ABC transporters for the pathogenesis and treatment of Huntington’s disease (HSØ)
• ABC-S1P: S1P and ABC transporters – synergistic treatment targets for Alzheimer´s disease (HSØ)
• REPURPOSE-DMF: Dimethyl fumarate – Repurposing a MS drug to treat AD (Nationalforeningen)
• ShortAbeta: Short Aβ-related peptides in the pathogenesis of Alzheimer’s disease – new avenues for treatment (LZPP Latvia)
• Establishment of comprehensive molecular diagnostics for kids’ brain tumours in Norway (Barnekreftforeningen)

See also www.pahnkelab.eu/funding/